ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and…
A Former Health System CEO, Mr. Statuto Has Over 30 Years of Leadership Experience CHARLES TOWN, W.V., March 7, 2025…
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation…
COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the…
FAIRFAX, Va., March 4, 2025 /PRNewswire/ -- Team Goldbelt, comprised of Goldbelt Apex, LLC, Knowesis, Inc., and zCore Business Solutions…
DELRAY BEACH, Fla., March 4, 2025 /PRNewswire/ -- The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million…
DALLAS, March 4, 2025 /PRNewswire/ -- Homecare HomebaseSM (HCHB), the leading software provider for home-based care, has named Janie "Heather"…
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheetSOUTH SAN FRANCISCO, Calif. and LOS ANGELES,…
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO,…
RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug…
